|
|
Volumn 40, Issue 1, 2000, Pages
|
|
Evaluation of omeprazole, lansoprazole, pantoprazole, and rabeprazole in the treatment of acid-related diseases.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
ANTIULCER AGENT;
BENZIMIDAZOLE DERIVATIVE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
LANSOPRAZOLE;
OMEPRAZOLE;
PANTOPRAZOLE;
PROTON PUMP;
RABEPRAZOLE;
SULFOXIDE;
DRUG ANTAGONISM;
FEMALE;
GASTROINTESTINAL DISEASE;
HUMAN;
PHYSIOLOGY;
REVIEW;
STOMACH ACID;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ANTI-ULCER AGENTS;
BENZIMIDAZOLES;
ENZYME INHIBITORS;
FEMALE;
GASTRIC ACID;
GASTROINTESTINAL DISEASES;
HUMANS;
OMEPRAZOLE;
PROTON PUMPS;
SULFOXIDES;
MLCS;
MLOWN;
|
|
EID: 0033631755
PISSN: 10865802
EISSN: None
Source Type: Journal
DOI: 10.1016/s1086-5802(16)31036-1 Document Type: Review |
|
Times cited : (141)
|
|
References (108)
|
